General MedicationsORALGeneric

CEPHALEXIN

Standard Dose

EQ 250MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons*

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview CEPHALEXIN is listed in Drugs@FDA under application 062117 (ANDA).

Marketing status: Discontinued Active ingredient CEPHALEXIN Form and strength FOR SUSPENSION;ORAL - EQ 250MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons* Sponsor FACTA FARMA Submission history Latest submission status date: 2000-05-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview CEPHALEXIN is listed in Drugs@FDA under application 062117 (ANDA). Marketing status: Discontinued Active ingredient CEPHALEXIN Form and strength FOR SUSPENSION;ORAL - EQ 250MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons* Sponsor FACTA FARMA Submission history Latest submission status date: 2000-05-01 00:00:00. Submission type: SUPPL.

Monitoring

• Review priority: STANDARD
• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.